Chemical Name    

CAS-Number

ICSC Short-Term Exposure

ICSC Long-Term Exposure

ICSC Routes of Exposure and Symptoms

US NIOSH Target Organs & Routes of Entry

US NIOSH Symptoms

BUTANE            106-97-8

Inhalation: drowsiness

Skin: on contact with liquid: frostbite

Eyes: on contact with liquid: frostbite

CNS inh; con (liq)

Drow, narco, asphy; liq: frostbite

CYCLOHEXANE  110-82-7

eyes; skin; upper resp tract; lungs

skin

Inhalation: dizziness, headache, nausea

Skin: redness

Eyes: redness

Eyes; resp sys; skin; CNS Inh; ing; con

Irrit eyes, skin, resp sys; drow; derm; narco, coma

CYCLOPENTANE     287-92-3

eyes; skin; upper resp tract; lungs; CNS

skin

Inhalation: dizziness, headache, nausea, unconsciousness, weakness

Skin: redness

Eyes: redness

Ingestion: abdominal pain, diarrhoea, dizziness, nausea, sore throat

Eyes; skin; resp sys; CNS Inh; ing; con

Irrit eys, skin, nose, throat; li-head, dizz, euph, inco, nau, vomit, stupor; dry, cracking skin

DECANE            124-18-5

lungs

skin; kidneys; blood

Inhalation: confusion, drowsiness

Skin: dry skin, redness

Eyes: redness, pain

ETHANE            74-84-0

skin

Inhalation: simple axphyxiant.

Skin: on contact with liquid: frostbite

Eyes: on contact with liquid: frosbite

HEPTANE          142-82-5

eyes; skin; resp tract; lungs; CNS

skin

Inhalation: dullness, headache

Skin: dry skin, burning sensation

Eyes: redness, pain

Ingestion: abdominal cramps, nausea, vomiting

Skin; resp sys; CNS Inh; ing; con

Li-head, gidd, stupor, verti, inco; loss of appetite, nau; derm; chemical pneu (aspir liq); uncon

HEXANE            110-54-3

eyes; skin; resp tract; lungs; CNS; liver

skin; PNS; genes

Inhalation: dizziness, drowsiness, dullness, headache, laboured breathing, nausea, unconsciousness, weakness

Skin: dry skin, redness

Eyes: redness, pain

Skin; eyes; resp sys; CNS; PNS Inh; ing; con

Irrit eyes, nose; li-head; nau, head; peri neur: numb extremities, musc weak; derm; gidd; chemical pneu (aspir liq)

2-METHYLBUTANE          78-78-4

eyes; skin; resp tract; lungs; heart

skin

Inhalation: cough, dizziness, drowsiness, headache, shortness of breath, sore throat, irregular heartbeat

Skin: dry skin, defats the skin redness

Eyes: redness, pain

Ingestion: abdominal pain, nausea, vomiting

METHYLCYCLOHEXANE     108-87-2

lungs; CNS

skin

Inhalation: dizziness, drowsiness

Skin: redness

Eyes: redness

Ingestion: nausea

Resp sys; skin; eyes; CNS Inh; ing; con

Irrit eyes, skin, nose, throat; li-head, drow; in animals: narco

2-METHYLHEPTANE     592-27-8

skin

Skin: redness

OCTANE            111-65-9

eyes; skin; resp tract; lungs

skin

Inhalation: confusion, dizziness, drowsiness, headache, laboured breathing, nausea, unconsciousness

Skin: dry skin, redness

Eyes: redness, painIngestion: vomiting

Skin; eyes; resp sys; CNS Inh; ing; con

Irrit eyes, nose; drow; derm; chemical pneu (aspir liq); in animals: narco

PENTANE          109-66-0

lungs; CNS

Inhalation: dizziness, drowsiness, headache, nausea, unconsciousness, vomiting

Skin: dry skin

Skin; eyes; resp sys; CNS Inh; ing; con

Irrit eyes, skin, nose; derm; chemical pneu (aspir liq); drow; in animals: narco

PROPANE          74-98-6

skin

Inhalation: simple axphyxiant.

Skin: on contact with liquid: frostbite

Eyes: on contact with liquid: frosbite

CNS Inh; con (liq)

Dizz, conf, excitation, asphy; liq: frostbite

2,2,4-TRIMETHYLPENTANE     540-84-1

eyes; skin; resp tract; kidneys; liver

skin; kidneys; liver

Inhalation: confusion, dizziness, headache, nausea, vomiting

Skin: redness, pain

Eyes: redness

Ingestion: vomiting

 

Back

Chemical Formula

Chemical

Synonyms
UN Code

CAS-Number

106978

BUTANE

n-Butane;
Diethyl;
Methylethylmethane
UN1011

106-97-8

110827

CYCLOHEXANE

Hexahydrobenzene;
Hexamethylene;
Hexanaphthene
UN1145

110-82-7

287923

CYCLOPENTANE

Pentamethylene
UN1146

287-92-3

75194

CYCLOPROPANE

Trimethylene
UN1027

75-19-4

124185

DECANE

UN2247

124-18-5

75832

2,2-DIMETHYLBUTANE

75-83-2

79298

2,3-DIMETHYLBUTANE

2,3-Dimethylbutane
UN2457

79-29-8

463821

2,2-DIMETHYLPROPANE

Neopentane
UN2044

463-82-1

74840

ETHANE

Bimethyl;
Dimethyl;
Ethyl hydride;
Methylmethane
UN1035
UN1961

74-84-0

142825

HEPTANE

Dipropyl methane;
n-Heptane;
Heptyl hydride
UN1206

142-82-5

110543

HEXANE

n-Hexane;
Hexyl hydride
UN1208

110-54-3

75285

ISOBUTANE

Propane, 2-methyl-
UN1969

75-28-5

107835

ISOHEXANE

107-83-5

78784

2-METHYLBUTANE

Ethyldimethylmethane;
Isoamylhydride;
Isopentane;
Isopentane
UN1265

78-78-4

108872

METHYLCYCLOHEXANE

Cyclohexylmethane;
Hexahydrotoluene;
Toluene hexahydride
UN2296

108-87-2

592278

2-METHYLHEPTANE

592-27-8

96140

3-METHYLPENTANE

96-14-0

111842

NONANE

n-Nonane

111-84-2

111659

OCTANE

n-Octane
UN1262

111-65-9

109660

PENTANE

UN1265

109-66-0

74986

PROPANE

Dimethylmethane;
Propyl hydride
UN1978

74-98-6

540841

2,2,4-TRIMETHYLPENTANE

Isobutyltrimethylmethane;
Isooctane

540-84-1

 

Back

Chemical Name
CAS-Number

Colour/Form

Boiling Point ( °C)

Melting Point ( °C)

Molecular Weight

Solubility in Water

Relative Density (water=1)

Relative Vapour Density (air=1)

Vapour Pressure/ (Kpa)

Inflam.
Limits

Flash Point (°C)

Auto Ignition Point ( °C)

ACRIDINE
260-94-6

rhombohedral needles or prisms from alcohol; monoclinic, orthorhombic; small colourless needles; orthorhombic plates, needles from diluted alcohol; small, colourless or faintly yellow crystals

346

111

179.21

sl sol

1.005

@ 129 °C

N-AMINOETHYL­PIPERAZINE
140-31-8

liquid

220

-17.6

129.2

sol

0.9837

4.4

93 oc

2-AMINOPYRIDINE
504-29-0

white leaflets or large colourless crystals; white powder or crystals

211

58

94.11

misc

3.25

0.13

68 cc

BENZOGUANAMINE
91-76-9

crystals

227

187.20

0.6%

@ 25 °C/4 °C

1,2,3-BENZOTRIAZOLE
95-14-7

needles from benzene; white to light tan, crystalline powder

@ 15 mm Hg

98.5

119.12

sl sol

COUMARIN
91-64-5

rhomboid, pyramidal crystals from ether; orthorhombic, rectangular plates; white, crystalline solid

301.72

71

146.14

1 g/ 400 ml (cold)

0.935 at 20/4 °C

1 mm Hg at 106.0 °C

3,4,5,6-DIBENZO­CARBAZOLE
194-59-2

needles from ethanol

158

267.34

3,6-DICHLORO­PICOLINIC ACID
1702-17-6

white crystalline solid; colourless crystals

151-152

192.0

@ 25 °C

0.8

0.003 Pa

N-ETHYLMORPHOLINE
100-74-3

colourless liquid

138.5

-62.78

115.2

misc

0.8996

4.0

@ 20 °C

2-MERCAPTO­BENZOTHIAZOLE
149-30-4

pale, yellow monoclinic needles or leaflets; yellowish powder; needles from alc or dilute methanol; yellowish to tan crystalline powder

181

167.2

insol

1.42

2-MERCAPTO­BENZOTHIAZOLE ­DISULPHIDE
120-78-5

pale yellow needles from benzene; free-flowing powder

180

332.46

insol

1.50

1-METHYL-2-­PYRROLIDONE
872-50-4

colourless liquid

202

24

99.13

v sol

@ 25 °C/ 25 °C

3.4

@ 25 °C

0.99 ll
3.9 ul

91

270

N-METHYLMORPHOLINE
109-02-4

115-116

101.14

sol

0.9051

2-METHYLPYRIDINE
109-06-8

colourless liquid

129

-70

93.12

v sol

0.9443

3.2

1.2

1.4 ll
8.6 ul

39

535

3-METHYLPYRIDINE
108-99-6

colourless liquid

143-144

-18.3

93.12

misc

@ 15 °C/4 °C

3.2

@ 25 °C

1.3 ll
8.7 ul

38 cc

4-METHYLPYRIDINE
108-89-4

colourless liquid

145

3.6

93.12

misc

0.9548

3.2

@ 25 °C

1.3 ll
8.7 ul

57 oc

MORPHOLINE
110-91-8

colourless liquid; mobile liquid

128.9

-4.9

87.12

misc

1.0007

3

1.06

2.0 ll
11.2 ul

38 oc

310

NICOTINE
54-11-5

colourless to pale yellow, oily liquid; thick, water-white, oil turning brown

@ 745 mm Hg

-79

162.23

misc

1.0097

5.61

@ 62 °C

0.7 ll
4.0 ul

95

244

NICOTINE TARTRATE
65-31-6

white plates

90

462.46

sol

N-NITROSONOR­NICOTINE
16543-55-8

yellow oil

@ 0.2 mm Hg

47

177.23

@ 154 °C

PHENAZOPYRIDINE
94-78-0

brownish-yellow crystals

139

213.25

@ 25 °C (est)

@ 25 °C

PHENOTHIAZINE
92-84-2

yellow, rhombic leaflets or diamond-shaped plates from toluene or butanol; yellow prisms from alcohol; grayish-­green to greenish yellow powder, granules or flakes

371

185.1

186.26

insol

PHENYLENEPYRENE
193-39-5

yellow plates or needles from light petroleum

530

162.5-164

insol

1.0x10- 10 torr

PIPERAZINE
110-85-0

plates or leaflets from ethanol; white to slightly off-white lumps or flakes; colourless, transparent, needle-like crystals

146

106

86.14

v sol

1.1

3.0

81 oc

PIPERAZINE DIHYDROCHLORIDE
142-64-3

cream coloured crystalline powder; white needles

159.07

41%

PIPERIDINE
110-89-4

clear, colourless liquid

@ 760 mm Hg

-7

85.15

v sol

0.8622

3.0

@ 29.2 °C

16 cc

1,3-PROPANE SULTONE
1120-71-4

colourless liquid or white crystals

@ 0.039 atm.

31

122.1

100 g/l

@ 40 °C/4 °C

PROPYLENE IMINE
75-55-8

colourless, oily liquid

66

-65

57.1

sol

@ 16 °C/4 °C

2.0

14.9

-39 cc

PYRIDINE
110-86-1

colourless liquid; slightly yellow

115.2

-42

79.10

misc

0.9819

2.73

2.0

1.8 ll
12.4 ul

17 cc

482

PYRIMIDINE
289-95-2

123.8

22

80.09

misc

PYRROLIDINE
123-75-1

colourless to pale yellow liquid

88.5-89

-57.8

71.12

misc

@ 22.5 °C/4 °C

2.45

@ 39 °C

@ -2°C

2-PYRROLIDINONE
616-45-5

liquid

@742 mm Hg

25

85.1

v sol

1.120

2.93

110 cc

QUINOLINE
91-22-5

colourless to brown liquid

237.7

-15

129.16

insol

1.0929

4.45

0.1

1.2 ll
7 ul

99

480

SULPHOLANE
126-33-0

white or creamy white, crystalline powder

285

27.4-27.8

120.16

misc

@ 30 °C/4 °C

@ 27.6 °C

177 oc

TETRAHYDRO­THIOPHENE
110-01-0

water-white liquid

121.0

-96.1

88.2

insol

0.9987

3.05

@ 25 °C

1.1 ll
12.1 ul

12

200

THIOPHENE
110-02-1

colourless liquid

84.16

-38.25

84.14

insol

1.06494

2.9

@ 12.5 °C

-1

2-VINYLPYRIDINE
100-69-6

colourless liquid

159-160

159-160

105.1

sl sol

0.9983

@ 44.5 °C

 

Back

Chemical Name
CAS-Number

Physical

Chemical

UN Class or Division /  Subsidiary Risks

N-AMINOETHYLPIPERAZINE
140-31-8

8

2-AMINOPYRIDINE
504-29-0

Dust explosion possible if in powder or granular form, mixed with air

The substance decomposes on burning producing toxic gases and vapours including nitrous oxides • Reacts with strong oxidants causing fire and explosion hazard • The substance is a strong base that is soluble in water

6.1

BENZOGUANAMINE
91-76-9

6.1

3,6-DICHLOROPICOLINIC ACID
1702-17-6

The substance decomposes on burning producing toxic and corrosive gases • Reacts with bases forming salts • Solutions of them are corrosive to aluminum, iron, and tin

2-MERCAPTOBENZOTHIAZOLE
149-30-4

On combustion, forms toxic gases (carbon monoxide and sulphur compounds) • The substance decomposes on heating and on burning producing toxic and irritating fumes (sulphur and nitrogen oxides) • Reacts with acids with the formation of highly toxic fumes of sulphur compounds • Reacts with acids or acid fumes producing toxic fumes (sulphur compounds)

2-MERCAPTOBENZOTHIAZOLE DISULPHIDE
120-78-5

On combustion, forms toxic gases: carbon, sulphur and nitrogen oxides • Reacts with strong oxidants and acids

2-METHYLPYRIDINE
109-06-8

The substance decomposes on heating producing toxic fumes (nitrogen oxides) • Reacts with oxidants and strong acids • Attacks copper and its alloys

3

3-METHYLPYRIDINE
108-99-6

The substance decomposes on heating producing toxic fumes (nitrogen oxides) • Reacts with oxidants and strong acids

3

4-METHYLPYRIDINE
108-89-4

The substance decomposes on heating producing toxic fumes (nitrogen oxides) • Reacts with oxidants and strong acids

3

1-METHYL-2-PYRROLIDONE
872-50-4

The substance decomposes on heating above 315 °C producing toxic fumes • Reacts with strong acids • Attacks aluminium

MORPHOLINE
110-91-8

The substance decomposes on heating producing toxic fumes (nitrogen oxides) • The substance is a weak base • Reacts with strong oxidants causing fire hazard • Attacks copper and its compounds

3

NICOTINE
54-11-5

The substance decomposes on heating producing toxic fumes • Reacts violently with strong oxidants • Attacks rubber and some plastics

NICOTINE TARTRATE
65-31-6

Shock-sensitive compounds are formed with this substance • The substance decomposes on heating producing toxic fumes • The substance is a strong reducing agent and reacts with oxidants

6.1

PHENOTHIAZINE
92-84-2

The substance decomposes on heating and on burning producing toxic and irritating fumes including nitrogen oxides and sulphur oxides

PHENYLENEPYRENE
193-39-5

Upon heating, toxic fumes are formed

PIPERAZINE
110-85-0

8

PIPERIDINE
110-89-4

The vapour is heavier than air and may travel along the ground; distant ignition possible

The substance decomposes on heating and on burning producing toxic gases such as nitrogen oxides • The substance is a medium strong base • Reacts violently with oxidants

3/ 8

PROPYLENE IMINE
75-55-8

3

PYRIDINE
110-86-1

The vapour is heavier than air and may travel along the ground; distant ignition possible

On combustion, forms toxic fumes (amines) • The substance decomposes on heating or on burning producing toxic fumes (nitrogen oxides and hydrogen cyanide) • Reacts violently with strong oxidants and strong acids

3

PYRROLIDINE
123-75-1

3/ 8

2-PYRROLIDINONE
616-45-5

The substance decomposes on heating producing toxic fumes • Reacts with strong acids cf • methylpyrrolidone • Attacks aluminium

QUINOLINE
91-22-5

The substance decomposes on heating and on burning producing toxic fumes of nitrogen oxides • Reacts with strong oxidants and maleine anhydride

6.1

TETRAHYDROTHIOPHENE
110-01-0

The vapour is heavier than air and may travel along the ground; distant ignition possible

On combustion, forms toxic fumes • Reacts violently with strong oxidants and nitric acid • Attacks rubber

3

THIOPHENE
110-02-1

The vapour is heavier than air and may travel along the ground; distant ignition possible • As a result of flow, agitation, etc, electrostatic charges can be generated

The substance decomposes on heating and on burning producing toxic and irritating fumes (sulphur oxides) • Reacts violently with oxidizing materials, including fuming nitric acid

3

2-VINYLPYRIDINE
100-69-6

6.1/ 3

For UN Class: 1.5 = very insensitive substances which have a mass explosion hazard; 2.1 = flammable gas; 2.3 = toxic gas; 3 = flammable liquid; 4.1 = flammable solid; 4.2 = substance liable to spontaneous combustion; 4.3 = substance which in contact with water emits flammable gases; 5.1 = oxidizing substance; 6.1 = toxic; 7 = radioactive; 8 = corrosive substance

 

Back

Sunday, 07 August 2011 06:37

Heterocyclic Compounds: Health Hazards

Chemical Name

CAS-Number

ICSC Short-Term Exposure

ICSC Long-Term Exposure

ICSC Routes of Exposure and Symptoms

US NIOSH Target Organs & Routes of Entry

US NIOSH Symptoms

2-AMINOPYRIDINE          504-29-0

Inhalation: convulsions, dizziness, headache, nausea, shortness of breath, weakness, increased blood pressure, collapse

CNS; resp sys Inh; abs; ing; con

Irrit eyes, nose, throat; head, dizz, excitement; nau; high BP; resp distress; weak; convuls; stupor

3,6-DICHLOROPICOLINIC ACID     1702-17-6

eyes; resp tract

liver; kidneys

Inhalation: cough, dullness

2-MERCAPTOBENZOTHIAZOLE     149-30-4

eyes

skin

Inhalation: cough

Skin: redness

Eyes: redness, pain

2-MERCAPTOBENZOTHIAZOLE DISULPHIDE      120-78-5

eyes; skin; resp tract

skin

Inhalation: cough, sore throat

Skin: may be absorbed, redness

Eyes: redness

2-METHYLPYRIDINE        109-06-8

eyes; skin; resp tract

skin; CNS

Inhalation: burning sensation, cough, dizziness, drowsiness, headache, laboured breathing, nausea, sore throat, unconsciousness, weakness

Skin: may be absorbed, dry skin, redness, burning sensation, pain, blisters

Eyes: pain, blurred vision, severe deep burns

Ingestion: abdominal pain, burning sensation, diarrhoea, vomiting

3-METHYLPYRIDINE        108-99-6

eyes; skin; resp tract

skin; CNS

Inhalation: burning sensation, cough, dizziness, drowsiness, headache, laboured breathing, nausea, sore throat, unconsciousness, weakness

Skin: may be absorbed, dry skin, redness, burning sensation, pain, blisters

Eyes: pain, blurred vision, severe deep burns

Ingestion: abdominal pain, burning sensation, diarrhoea, vomiting

4-METHYLPYRIDINE        108-89-4

eyes; skin; resp tract

skin; CNS

Inhalation: burning sensation, cough, dizziness, drowsiness, headache, laboured breathing, nausea, sore throat, unconsciousness, weakness

Skin: may be absorbed, dry skin, redness, burning sensation, pain, blisters

Eyes: pain, blurred vision, severe deep burns

Ingestion: abdominal pain, burning sensation, diarrhoea, vomiting

1-METHYL-2-PYRROLIDONE     872-50-4

resp tract; eyes

lungs; bone marrow; lymphatic system

Inhalation: cough, laboured breathing

Skin: may be absorbed

Eyes: redness, pain, blurred vision, loss of vision; abdominal cramps, diarrhoea, laboured breathing

MORPHOLINE    110-91-8

eyes; skin; resp tract; lungs

liver; kidneys

Inhalation: Ingestion: burning sensation, cough, laboured breathing, shortness of breath, sore throat

Skin: may be absorbed, redness, skin burns, pain

Eyes: redness, pain, blurred vision

Ingestion: abdominal pain, cough, diarrhoea, vomiting

Resp sys; eyes; skin; liver; kidneys Inh; abs; ing; con

Irrit eyes, skin, nose, resp sys; vis dist; cough; in animals: liver, kidney damage

NICOTINE          54-11-5

Inhalation: abdominal pain, headache, nausea, vomiting, tremors, convulsions,

CNS; CVS; lungs; GI tract; repro sys Inh; abs; ing; con

Nau, salv, abdom pain, vomit, diarr; head, dizz, hearing, vis dist; conf, weak, inco; paroxysmal atrial fibrl; convuls, dysp; in animals: terato effects

NICOTINE TARTRATE      65-31-6

eyes; skin; CNS

Inhalation: abdominal pain, headache, nausea, vomiting, tremors, convulsions

Skin: may be absorbed

Eyes: redness, pain

PHENOTHIAZINE            92-84-2

eyes; skin; resp tract; blood; liver

skin

Inhalation: cough, sore throat

Skin: may be absorbed, redness, pain, itching, coloured yellow-brown skin

Eyes: redness, pain, blurred vision

Skin; CVS; liver; kidneys Inh; abs; ing; con

Itching, irrit, reddening skin; hepatitis, hemolytic anemia, abdom cramps, tacar; kidney damage; skin photo sens

PHENYLENEPYRENE      193-39-5

Skin: may be absorbed

PIPERIDINE       110-89-4

Inhalation: burning sensation, cough, laboured breathing

PROPYLENE IMINE         75-55-8

eyes; skin; resp tract; lungs ; CNS

skin

Inhalation: cough, dizziness, headache, laboured breathing, shortness of breath, unconsciousness

Skin: may be absorbed, redness, skin burns, itching, blisters

Eyes: redness, pain, blurred vision

Ingestion: burning sensation of the digestive tract, dizziness, headache, nausea, vomiting

Eyes; skin (in animals: nasal tumors) Inh; abs; ing; con

Eye, skin burns; (carc)

PYRIDINE          110-86-1

eyes; skin; resp tract; GI tract; CNS; CVS

skin; liver; kidneys

Inhalation: cough, dizziness, headache, nausea, shortness of breath, unconsciousness

Skin: may be absorbed, redness

Eyes: redness, pain

Ingestion: abdominal pain, diarrhoea, vomiting, weakness

Eyes; skin; CNS; liver; kidneys; GI tract Inh; abs; ing; con

Irrit eyes; head, ner, dizz, insom; nau, anor, derm; liver, kidney damage

2-PYRROLIDINONE         616-45-5

eyes

QUINOLINE        91-22-5

eyes; resp tract; CNS

liver; kidneys; retina

Inhalation: cough, laboured breathing, nausea, shortness of breath, vomiting, weakness

Skin: may be absorbed, redness, skin burns

Eyes: redness, pain, blurred vision

TETRAHYDROTHIOPHENE     110-01-0

eyes; skin; resp tract; CNS

skin

Inhalation: Burning sensation, cough, headache, sore throat

Skin: may be absorbed, dry skin, redness, burning sensation

Eyes: redness, pain, eyes

Ingestion: abdominal pain

THIOPHENE       110-02-1

eyes; skin; resp tract

Inhalation: cough, sore throat

Skin: may be absorbed

Eyes: redness, pain

 

Back

Chemical Formula

Chemical

Synonyms
UN Code

CAS-Number

1888911

N-ACETYLCAPROLACTAM

Acetylcaprolactam;
2H-Azepin-2-one, 1-acetylhexahydro-

1888-91-1

260946

ACRIDINE

Benzo(b)quinoline;
2,3-Benzoquinoline;
Dibenzo(b,e)pyridine
UN2713

260-94-6

140318

N-AMINOETHYLPIPERAZINE

N-(2-Aminoethyl)piperazine;
1-(2-Aminoethyl)piperazine
UN2815

140-31-8

504290

2-AMINOPYRIDINE

o-Aminopyridine;
a-Aminopyridine;
2-Aminopyridine;
Amino-2-pyridine;
a-Pyridinamine;
a-Pyridylamine;
2-Pyridylamine
UN2671

504-29-0

91769

BENZOGUANAMINE

4,6-Diamino-2-phenyl-s-triazine;
2-Phenyl-4,6-diamino-s-triazine;
2-Phenyl-4,6-diamino-1,3,5-triazine

91-76-9

95147

1,2,3-BENZOTRIAZOLE

1,2,-Aminozophenylene;
Aziminobenzene;
Benzene azimide;
Benzisotriazole;
1,2,3-Benzotriazole;
Benztriazole;
1H-Triazaindene

95-14-7

91645

COUMARIN

91-64-5

194592

3,4,5,6-DIBENZOCARBAZOLE

3,4,5,6-Dibenzcarbazol;
3,4,5,6-Dinaphthacarbazole;
7H-Dibenzo(C,G)carbazole

194-59-2

1702176

3,6-DICHLOROPICOLINIC ACID

3,6-Dichloro-2-pyridinecarboxylic acid;
2-Pyridinecarboxylic acid, 3,6-Dichloro-

1702-17-6

100743

N-ETHYLMORPHOLINE

4-Ethylmorpholine

100-74-3

149304

2-MERCAPTOBENZOTHIAZOLE

Benzothiazole-2-thione;
2(3H)-Benzothiazolethione;
2-Benzothiazolyl mercaptan;
Mercaptobenzothiazole;
2-Mercaptobenzothiazole

149-30-4

120785

2-MERCAPTOBENZOTHIAZOLE DISULPHIDE

2-Benzothiazolyl disulphide;
Benzothiazyl disulphide;
Bis(benzothiazolyl) disulphide;
Bis(2-benzothiazyl) disulphide;
Dibenzothiazolyl disulphide;
Dibenzothiazyl disulphide;
Dibenzoylthiazyl disulphide;
Dibenzthiazyl disulphide;
2,2'-Dithiobis(benzothiazole);
2-Mercaptobenzothiazole disulphide;
2-Mercaptobenzothiazyl disulphide

120-78-5

109024

N-METHYLMORPHOLINE

Methylmorpholine;
4-Methylmorpholine
UN2535

109-02-4

872504

1-METHYL-2-PYRROLIDINONE

N-Methylpyrrolidinone;
N-Methyl-2-pyrrolidinone;
1-Methyl-5-pyrrolidinone;
N-Methylpyrrolidone;
N-Methyl-a-Pyrrolidone;
1-Methyl-2-pyrrolidone

872-50-4

109068

2-METHYLPYRIDINE

a-Methylpyridine;
2-Picoline ;
a-Picoline

109-06-8

108996

3-METHYLPYRIDINE

3-Picoline

108-99-6

108894

4-METHYLPYRIDINE

g-Picoline;
4-Picoline

108-89-4

110918

MORPHOLINE

Diethyleneimide oxide;
Diethylene imidoxide;
Diethylene oximide;
Diethylenimide oxide;
Drewamine;
p-Isoxazine, tetrahydro-;
Tetrahydro-;
Tetrahydro-1,4-isoxazine;
Tetrahydro-1,4-oxazine
UN2054

110-91-8

54115

NICOTINE

1-Methyl-2-(3-pyridyl)pyrrolidine;
3-(N-Methylpyrrolidino)pyridine;
L-nicotine;
3-(Tetrahydro-1-methylpyrrol-2-yl);
a-Pyridyl-a-N-Methylpyrrolidine;
Pyrrolidine, 1-Methyl-2-(3-pyridal)-;
Tetrahydronicotyrine
UN1654

54-11-5

65316

NICOTINE TARTRATE

Nicotine acid tartrate;
Nicotine bitartrate;
Nicotine hydrogen tartrate
UN1659

65-31-6

16543558

N-NITROSONORNICOTINE

1'-Nitroso-1'-demethylnicotine;
1-Nitroso-2-(3-pyridyl)pyrrolidine;
3-(1-Nitroso-2-pyrrolidinyl)pyridine;
Pyridine, 3-(1-nitroso-2-pyrrolidinyl)-, (s)-

16543-55-8

94780

PHENAZOPYRIDINE

2,6-Diamino-3-phenylazopyridine;
Phenazodine;
3-(Phenylazo)-2,6-pyridinediamine;
Phenazopyridine;
2,6-Pyridinediamine, 3-(phenylazo)-;
Pyridium;
Pyripyridium

94-78-0

92842

PHENOTHIAZINE

Dibenzoparathiazine;
Dibenzothiazine;
Dibenzo-1,4-thiazine

92-84-2

193395

PHENYLENEPYRENE

Indeno(1,2,3-CD)pyrene;
o-Phenylenepyrene;
2,3-;
2,3-o-Phenylenepyrene;
1,10-(o-Phenylene)pyrene;
1,10-(1,2-Phenylene)pyrene

193-39-5

110850

PIPERAZINE

1,4-Diethylenediamine;
Hexahydro-1,4-diazine;
Hexahydropyrazine;
Piperazidine;
Piperazine ;
Piperazine, anhydrous;
Pyrazine hexahydride
UN2579

110-85-0

142643

PIPERAZINE DIHYDROCHLORIDE

Dihydrochloride salt of diethylenediamine;
Dowzene DHC;
Piperazine hydrochloride

142-64-3

110894

PIPERIDINE

Azacyclohexane;
Cyclopentimine;
Hexahydropyridine;
Hexazane;
Pentamethyleneimine;
Pentamethylenimine;
Piperidine ;
Pyridine, hexahydro-
UN2401

110-89-4

1120714

1,3-PROPANE SULTONE

3-Hydroxy-1-propanesulphonic acid sulphone;
3-Hydroxy-1-propanesulphonic acid sultone;
1,2-Oxathrolane 2,2-dioxide

1120-71-4

75558

PROPYLENE IMINE

2-Methylazacyclopropane;
2-Methylaziridine;
Methylethylenimine;
2-Methylethylenimine;
Propylene imine;
1,2-Propyleneimine
UN1921

75-55-8

110861

PYRIDINE

UN1282

110-86-1

289952

PYRIMIDINE

1,3-Diazabenzene;
m-Diazine;
Metadiazine

289-95-2

123751

PYRROLIDINE

Azacyclopentane;
Azolidine;
Prolamine;
Pyrrole, tetrahydro-;
Pyrrolidine;
Tetrahydropyrrole;
Tetramethylenimine
UN1922

123-75-1

616455

2-PYRROLIDINONE

4-Aminobutyric acid lactam;
Butyrolactam;
2-Oxopyrrolidine;
a-Pyrrolidinone;
Pyrrolidone;
2-Pyrrolidone

616-45-5

91225

QUINOLINE

1-Azanaphthalene;
1-Benzazine;
1-Benzine;
Benzo(b)pyridine;
Quinoline
UN2656

91-22-5

126330

SULPHOLANE

Cyclic tetramethylene sulphone;
Cyclotetramethylene sulphone;
Dihydrobutadiene sulphone;
1,1-Dioxidetetrahydrothiofuran;
1,1-Dioxidetetrahydrothiophene;
Sulphalone;
Sulpholan;
Tetrahydrothiophene dioxide

126-33-0

110010

TETRAHYDROTHIOPHENE

Tetrahydrothiophene;
Tetramethylenesulphide;
Thiacyclopentane;
Thilane;
Thiophane
UN2412

110-01-0

110021

THIOPHENE

Divinylene sulphide;
Thiacyclopentadiene;
Thiaphene;
Thiofuran;
Thiofuram;
Thiofurfuran;
Thiole;
Thiophen
UN2414

110-02-1

100696

2-VINYLPYRIDINE

100-69-6

 

Back

Chemical Name
CAS-Number

Colour/Form

Boiling Point (°C)

Melting Point (°C)

Molecular Weight

Solubility in Water

Relative Density (water=1)

Relative Vapour Density (air=1)

Vapour Pressure/ (Kpa)

Inflam.
Limits

Flash Point (°C)

Auto Ignition Point (°C)

BROMINE
7726-95-6

dark reddish-brown liquid; reddish-brown vapor; rhombic crystals

58.78

-7.25

159.808

3.58 g/ 100 ml

@ 25 °C/4 °C

@ 15 °C

23.3

BROMINE PENTAFLUORIDE
7789-30-2

colourless liquid; colourless gas above 40.3 °C

40.76

-60.5

174.90

reacts

@ 25 °C

6.05

@ 25.5 °C

CARBONYL FLUORIDE
353-50-4

colourless gas

-83

-114

66.01

reacts

@ 25 °C

2.3

CHLORINE
7782-50-5

greenish-yellow, diatomic gas

-34.6

-100.98

70.906

@ 30 °C

1.4085;6.864 atm

2.5

638

CHLORINE OXIDE
10049-04-4

yellow to reddish-yellow gas at room temp; solid chlorine dioxide is a yellowish-red crystalline mass; liquid is reddish-brown

11

-59

67.46

@ 25 °C and 34.5 mm Hg

@ 0 °C

2.3

10

>10

CHLORINE TRIFLUORIDE
7790-91-2

colourless gas; liquid is yellow-green in colour; solid is white

11.75

-76.34

92.46

reacts

@ 13 °C

3.18

@ -4.9 °C; 740 mm Hg

FLUORINE
7782-41-4

pale yellow; greenish yellow gas

-188.13

-219.61

37.99

reacts

@ -188.2 °C

1.3

@ -223.0 °C; 10 mm Hg

HYDROGEN FLUORIDE
7664-39-3

colourless liquid

20

-83

20.0

misc

@ 19.54 °C

@ 0 °C

@ 2.5 °C

IODINE
7553-56-2

bluish-black scales or plates; diatomic; rhombic, violet-black crystals with metallic luster

184.35

113.50

253.81

@ 25 °C (solid)

6.75 g/l (gas)

@ 38.7 °C (solid)

NITROGEN CHLORIDE
10025-85-1

yellow oil ot rhombic crystals

<71

<-40

120.37

insol cold water, decomposes hot water

1.653

NITROGEN TRIFLUORIDE
7783-54-2

colourless gas

-129

-208.5

71.01

sl sol

@ -129 °C (liquid)

OXYGEN DIFLUORIDE
7783-41-7

colourless gas; yellowish-brown when liquid

-144.8

-223.8

54.00

insol hot water; sl sol and decomposes cold water

@ -233.8 °C (liquid)

1.8

@ -144.6 °C

PERCHLORYL FLUORIDE
7616-94-6

colourless gas

-46.8

-146

102.45

misc

0.637 (gas); 1.434 (liquid)

3.5

1.06

PHOSGENE
75-44-5

colourless gas

8

-118

98.92

sl sol

1.381

3.4

161.6

PHOSPHORUS PENTABROMIDE
7789-69-7

yellow crystalline mass

106 decomp

430.49

decomposes

PHOSPHOROUS TRIBROMIDE
7789-60-8

colourless liquid; pale yellow liquid

173.2

-41.5

270.73

@ 15 °C

@ 47.8 °C

SODIUM HEXAFLUOROSILICATE
16893-85-9

white granular powder

188.05

sol

2.68

SULPHUR CHLORIDE
10025-67-9

light amber to yellowish red oily liquid

135.6

-77

135.03

reacts

@ 15.5 °C/­15.5 °C

4.66

0.906

118 cc

234

SULPHUR DICHLORIDE
10545-99-0

dark red liquid; *reddish brown liquid

59 (decomp)

-78

102.96

@ 15 °C/15 °C

3.55

@ -23 °C

SULPHUR HEXAFLUORIDE
2551-62-4

colourless gas; liquid at -50.5 °C

-63.8 sublimes

-50.8

146.06

sl sol

@ -50 °C (liquid)

5.1

2140

SULPHURYL FLUORIDE
2699-79-8

colourless gas

-55.38

-135.82

102.07

4-5 ml gas/ 100 ml

3.72 g/l (gas), 1.7 g/l (liquid)

3.5

@ 25 °C

 

Back

Chemical Name
CAS-Number

Physical

Chemical

UN Class or Division /  Subsidiary Risks

BROMINE
7726-95-6

The vapour is heavier than air

Upon heating, toxic fumes are formed • The substance is a strong oxidant and reacts violently with combustible and reducing materials • Reacts violently with aqueous ammonia, oxidants, metals, organic compounds and phosphorus causing fire and explosion hazard • Attacks some forms of plastic, rubber and coatings

3/ 6.1

BROMINE PENTAFLUORIDE
7789-30-2

The vapour is heavier than air

The substance decomposes on heating above 460 °C and on contact with acid or acid fumes producing very toxic fumes of fluorine and bromine • Reacts violently with fuels and organic compounds, hydrogen containing material (such as ammonia, acetic acid, grease, paper) causing fire and explosion hazard • Reacts explosively with water or steam to produce toxic and corrosive fumes • Reacts with all known elements, except nitrogen, oxygen and rare gases

5.1/ 6.1/ 8

CARBONYL FLUORIDE
353-50-4

The gas is heavier than air

The substance decomposes on heating at 450-490 °C producing toxic gases • Hydrolyzed rapidly by water to form carbon dioxide and hydrogen fluoride

2.3/ 8

CHLORINE
7782-50-5

The gas is heavier than air

Reacts violently with many organic compounds, ammonia and finely divided metals causing fire and explosion hazard • Attacks many metals in presence of water • Attacks plastic, rubber and coatings

2.3/ 5.1/ 8

CHLORINE OXIDE
10049-04-4

The gas is heavier than air

May explosively decompose on shock, friction, or concussion • May explode on heating • The substance is a strong oxidant and reacts violently with combustible and reducing materials • Reacts violently with mercury, phosphorus, sulphur and many compounds, causing fire and explosion hazard • Reacts with water producing hydrochloric acid and chloric acid

CHLORINE TRIFLUORIDE
7790-91-2

The gas is heavier than air and corrosive

The substance decomposes above 220 °C producing toxic gases (chlorine and fluorine compounds) • Reacts violently with water, sand, silicon-containing compounds, glass, and asbestos • Reacts with all forms of plastics, rubber, and resins, except the highly fluorinated polymers • Most combustible materials ignite spontaneously on contact with this substance • Reacts violently with oxidizable materials, metals and metal oxides • Explodes in contact with organic materials • Emits highly toxic fumes on contact with acids

2.3/ 5.1/ 8

FLUORINE
7782-41-4

The gas is heavier than air

The substance is a strong oxidant and reacts violently with combustible and reducing materials • Reacts violently with water producing toxic and corrosive vapours: ozone and hydrogen fluoride • Reacts violently with ammonia, metals, oxidants, and many other materials, causing fire and explosion hazard

2.3/ 5.1/ 8

HYDROGEN BROMIDE
10035-10-6

The gas is heavier than air

The solution in water is a strong acid, it reacts violently with bases and is corrosive • Reacts violently with strong oxidants and many organic compounds causing fire and explosion hazard • Attacks many metals forming flammable hydrogen gas

8

HYDROGEN FLUORIDE
7664-39-3

The solution in water is a strong acid, it reacts violently with bases and is corrosive • Reacts violently with many compounds causing fire and explosion hazard • On contact with air it emits corrosive fumes which are heavier than air and will spread along the ground • Attacks glass and other silicon-containing compounds

3/ 6.1

NITROGEN TRIFLUORIDE
7783-54-2

2.3/ 5.1

OXYGEN DIFLUORIDE
7783-41-7

The gas is heavier than air

The substance decomposes on heating above 250 °C producing toxic fumes (fluorine) • The substance is a strong oxidant and reacts violently with combustible and reducing materials • Reacts explosively with hydrogen sulfide at ambient temperature, with chlorine, bromine or iodine on warming • Attacks mercury • Explodes on contact with steam • Reaction of oxygen difluoride with non-metals such as red phosphorous and boron powder and silica, alumina or similar surface-active solids is exothermic and may be explosive

2.3/ 5.1/ 8

PERCHLORYL FLUORIDE
7616-94-6

The substance decomposes on heating producing toxic fumes (fluorine, fluorine oxides, chlorine, chlorine oxides) • The substance is a strong oxidant and reacts violently with combustible and reducing materials, causing fire and explosion hazard • Attacks some forms of plastics, rubber and coatings

2.3/ 5.1

PHOSGENE
75-44-5

The vapour is heavier than air and may travel along the ground

The substance decomposes on heating above 300 °C, producing toxic and corrosive gases: hydrogen chloride and carbon monoxide, chlorine fumes • Reacts violently with strong oxidants • Reacts slowly with water producing corrosive, pungent and toxic gases • Reacts violently with amines, with aluminium • Attacks many metals in presence of water • Attacks metal, plastic, rubber

2.3/ 8

PHOSPHORUS PENTABROMIDE
7789-69-7

8

PHOSPHOROUS TRIBROMIDE
7789-60-8

8

SULPHUR CHLORIDE
10025-67-9

On combustion, forms toxic gases and vapours (such as hydrogen chloride, sulphur dioxide, hydrogen sulfide) • The substance decomposes to toxic chlorine gas and solid sulphur on heating above 300 °C • Reacts with peroxides, oxides of phosphorous and some organic compounds, causing fire and explosion hazard • Reacts with moist air to form corrosive vapours (hydrochloric acid) • Contact with water causes a violent reaction, forming hydrogen chloride gas (or hydrochloric acid), sulphur dioxide, sulphur, sulfite, thiosulfate and hydrogen sulfide, which may corrode metal containers and form flammable hydrogen gas

8

SULPHUR DICHLORIDE
10545-99-0

8

SULPHUR HEXAFLUORIDE
2551-62-4

The gas is heavier than air and may accumulate in low ceiling spaces causing deficiency of oxygen

The substance decomposes in a fire producing toxic fumes of sulphur oxides and hydrogen fluoride • on contact with hot surfaces producing S02 • Upon heating, toxic fumes are formed • Reacts with strong oxidants and alkali and earth alkali

2.2

SULFURYL FLUORIDE
2699-79-8

2.3

For UN Class: 1.5 = very insensitive substances which have a mass explosion hazard; 2.1 = flammable gas; 2.3 = toxic gas; 3 = flammable liquid; 4.1 = flammable solid; 4.2 = substance liable to spontaneous combustion; 4.3 = substance which in contact with water emits flammable gases; 5.1 = oxidizing substance; 6.1 = toxic; 7 = radioactive; 8 = corrosive substance

 

Back

Chemical Name

CAS-Number

ICSC Short-Term Exposure

ICSC Long-Term Exposure

ICSC Routes of Exposure and Symptoms

US NIOSH Target Organs & Routes of Entry

US NIOSH Symptoms

BROMINE          7726-95-6

eyes; skin; resp tract; lungs

skin; lungs

Inhalation: corrosive, burning sensation, cough, dizziness, headache, laboured breathing, sore throat

Skin: corrosive, redness, skin burns, pain

Eyes: corrosive, redness, pain, severe deep burns

Ingestion: corrosive, abdominal cramps, burning sensation, sore throat, collapse

Resp sys; eyes; CNS; skin Inh; ing; con

Dizz, head; lac, epis; cough, feeling of oppression, pulm edema, pneu; abdom pain, diarr; measle-like eruptions; eye, skin burns

BROMINE PENTAFLUORIDE     7789-30-2

eyes; skin; resp tract; lungs

liver; kidneys; resp tract

Inhalation: burning sensation, cough, shortness of breath, sore throat

Skin: skin burns, pain, blisters

Eyes: pain, blurred vision, severe deep burns

Ingestion: abdominal pain, burning sensation

Eyes; skin; resp sys; liver; kidneys Inh; ing; con

Irrit eyes, skin, resp sys; corn nec; skin burns; cough; dysp, pulm edema; liver, kidney inj

CARBONYL FLUORIDE     353-50-4

eyes; skin; resp tract; lungs; skin

blood

Inhalation: cough, laboured breathing, sore throat, symptoms may be delayed

Skin: redness, on contact with liquid: frostbite

Eyes: redness

Eyes; skin; resp sys; bone Inh; con

Irrit eyes, skin, muc memb, resp sys; eye, skin burns; lac; cough; pulm edema, dysp; chronic exposure: GI pain, musc fib, skeletal fluorosis; liq: frostbite

CHLORINE         7782-50-5

eyes; skin; resp tract; lungs; skin

lungs

Inhalation: corrosive, burning sensation, cough, headache, laboured breathing, nausea, shortness of breath, sore throat, symptoms may be delayed

Skin: corrosive, skin burns, pain

Eyes: corrosive, pain, blurred vision, severe deep burns

Resp sys, eyes, skin Inh; con

Burning of eyes, nose, mouth; lac, rhin; cough, choking, subs pain; nau, vomit; head, dizz; syncope; pulm edema; pneu; hypox; derm; liq: frostbite

CHLORINE OXIDE     10049-04-4

eyes; skin; resp tract; lungs; skin

lungs

Inhalation: corrosive, cough, headache, laboured breathing, nausea, shortness of breath, sore throat, symptoms may be delayed

Skin: corrosive, redness, serious skin burns, pain

Resp sys; eyes Inh; ing (liq); con

Irrit eyes, nose, throat; cough, wheez, bron, pulm edema; chronic bron

CHLORINE TRIFLUORIDE     7790-91-2

eyes; skin; resp tract; lungs

Inhalation: cough, laboured breathing, sore throat

Skin: corrosive, redness, serious skin burns, pain

Eyes: permanent loss of vision, severe deep burns, blindness

Skin; eyes; resp sys Inh; ing (liq); con

Eye, skin burns (liq or high vap conc); resp irrit; in animals: lac; corn ulcer; pulm edema

FLUORINE         7782-41-4

eyes; skin; resp tract; lungs

skin

Inhalation: corrosive, cough, shortness of breath, sore throat, choking

Skin: corrosive, redness, serious skin burns, on contact with liquid: frostbite

Eyes: redness, severe deep burns

Resp sys; eyes; liver; kidneys Inh; con

Irrit eyes, nose, resp sys; lar spasm, bron spasm; pulm edema; eye, skin burns; in animals: liver, kidney damage

HYDROGEN FLUORIDE     7664-39-3

eyes; skin; resp tract; lungs

Inhalation: cough, laboured breathing, sore throat, symptoms may have delayed effects

Skin: may be adsorbed, serious skin burns

Eyes: redness, pain, blurred vision

Ingestion: abdominal pain, diarrhoea, sore throat, vomiting, symptoms may have delayed effects

Eyes; resp sys; skin; bone Inh; abs (liq); ing (soln); con

Irrit eyes, skin, nose, throat; pulm edema; eye, skin burns; rhinitis; bron; bone changes

OXYGEN DIFLUORIDE     7783-41-7

eyes; skin; resp tract; lungs

Inhalation: cough, laboured breathing, sore throat

Skin: on contact with liquid: frostbite

Resp sys; eyes; skin Inh; con

Irrit eyes, skin, resp sys; head; pulm edema; eye, skin burns (from contact with the gas under pressure)

PERCHLORYL FLUORIDE     7616-94-6

resp tract; skin

blood

Inhalation: headache

Skin: on contact with liquid: frostbite

Eyes: severe deep burns

Resp sys; skin; blood Inh; con (liq)

Irrit resp sys; liq: frostbite; in animals: methemo; cyan; weak; dizz, head; pulm edema; pneuitis; anoxia

PHOSGENE       75-44-5

eyes; skin; resp tract; lungs

lungs

Inhalation: corrosive, burning sensation, cough, laboured breathing, shortness of breath, sore throat

Resp sys; skin; eyes Inh; con (liq)

Irrit eyes; dry, burning throat; vomit; cough, foamy sputum, dysp, chest pain, cyan; liq: frostbite

SULPHUR CHLORIDE     10025-67-9

eyes; skin; resp tract; lungs; corrosive on ingestion

skin

Inhalation: burning sensation, cough, headache, laboured breathing, nausea, vomiting

Skin: redness, skin burns, burning sensation, pain, blisters

Eyes: redness, pain, severe deep burns

Resp sys; skin; eyes Inh; ing; con

Irrit eyes, skin, muc memb; lac; cough; eye, skin burns; pulm edema

SULPHUR HEXAFLUORIDE     2551-62-4

skin

Skin: on contact with liquid: frostbite

Eyes: corneal damage

Resp sys Inh

Asphy: incr breath rate, pulse rate; slight musc inco, emotional upset; ftg, nau, vomit, convuls

SULPHUR PENTAFLUORIDE     5714-22-7

Resp sys; CNS; eyes; skin Inh; ing; con

Irrit eys, skin, resp sys; in animals: pulm edema, hemorr

 

Back

Chemical Formula

Chemical

Synonyms
UN Code

CAS-Number

7726956

BROMINE

Bromine
UN1744

7726-95-6

7789302

BROMINE PENTAFLUORIDE

Bromine pentafluoride
UN1745

7789-30-2

7789755

CALCIUM FLUORIDE

7789-75-5

353504

CARBONYL FLUORIDE

Carbon difluoride oxide;
Carbon fluoride oxide;
Carbon oxyfluoride;
Carbonyl difluoride;
Difluoroformaldehyde;
Fluophosgene;
Fluoroformyl fluoride;
Fluorophosgene
UN2417

353-50-4

7782505

CHLORINE

Molecular chlorine
UN1017

7782-50-5

10049044

CHLORINE OXIDE

Chlorine dioxide;
Chlorine(IV) oxide;
Chlorine peroxide;
Chloroperoxyl

10049-04-4

7790912

CHLORINE TRIFLUORIDE

Chlorine fluoride;
Chlorotrifluoride
UN1749

7790-91-2

7782414

FLUORINE

Fluorine
UN1045

7782-41-4

10035106

HYDROGEN BROMIDE

Anhydrous hydrobromic acid;
Hydrobromic acid solution
UN1788

10035-10-6

7664393

HYDROGEN FLUORIDE

Hydrofluoric acid;
Hydrofluoride
UN1052
UN1790

7664-39-3

7553562

IODINE

7553-56-2

10025851

NITROGEN CHLORIDE

Chlorine nitride;
Nitrogen trichloride;
Trichloramine;
Trichlorine nitride

10025-85-1

7783542

NITROGEN TRIFLUORIDE

Nitrogen fluoride
UN2451

7783-54-2

7783417

OXYGEN DIFLUORIDE

Fluorine monoxide;
Fluorine oxide;
Oxygen fluoride
UN2190

7783-41-7

7616946

PERCHLORYL FLUORIDE

Chlorine fluoride oxide;
Chlorine oxyfluoride
UN3083

7616-94-6

75445

PHOSGENE

Carbonyl chloride;
Carbonyl dichloride;
Chloroformyl chloride
UN1076

75-44-5

7789697

PHOSPHOROUS PENTABROMIDE

7789-69-7

7789608

PHOSPHOROUS TRIBROMIDE

Phosphorous bromide;
Tribromophosphine
UN1808

7789-60-8

16893859

SODIUM HEXAFLUOROSILICATE

16893-85-9

10025679

SULPHUR CHLORIDE

Disulphurdichloride;
Sulphurmonochloride;
Sulphurisubchloride;
Thiosulphurous dichloride

10025-67-9

10545990

SULPHUR DICHLORIDE

10545-99-0

2551624

SULPHUR HEXAFLUORIDE

Sulphurfluoride
UN1080

2551-62-4

5714227

SULPHUR PENTAFLUORIDE

Disulphurdecafluoride;
Sulphurdecafluoride

5714-22-7

2699798

SULPHURYL FLUORIDE

Sulphuric oxyfluoride
UN2191

2699-79-8

 

Back

Page 10 of 122

" DISCLAIMER: The ILO does not take responsibility for content presented on this web portal that is presented in any language other than English, which is the language used for the initial production and peer-review of original content. Certain statistics have not been updated since the production of the 4th edition of the Encyclopaedia (1998)."

Contents

Health Care Facilities and Services References

Abdo, R and H Chriske. 1990. HAV-Infektionsrisiken im Krankenhaus, Altenheim und Kindertagesstätten. In Arbeitsmedizin im Gesundheitsdienst, Band 5, edited by F Hofmann and U Stössel. Stuttgart: Gentner Verlag.

Acton, W. 1848. On the advantages of caouchoue and gutta-percha in protecting the skin against the contagion of animal poisons. Lancet 12:588.

Ahlin, J. 1992. Interdisciplinary case studies in offices in Sweden. In Corporate Space and Architecture. Vol. 2. Paris: Ministére de l’équipment et du logement.

Akinori, H and O Hiroshi. 1985. Analysis of fatigue and health conditions among hospital nurses. J Science of Labour 61:517-578.

Allmeers, H, B Kirchner, H Huber, Z Chen, JW Walter, and X Baur. 1996. The latency period between exposure and the symptoms in allergy to natural latex: Suggestions for prevention. Dtsh Med Wochenschr 121 (25/26):823-828.

Alter, MJ. 1986. Susceptibility to varicella zoster virus among adults at high risk for exposure. Infec Contr Hosp Epid 7:448-451.

—. 1993. The detection, transmission, and outcome of hepatitis C infection. Infect Agents Dis 2:155-166.

Alter, MJ, HS Margolis, K Krawczynski, FN Judson, A Mares, WJ Alexander, PY Hu, JK Miller, MA Gerber, and RE Sampliner. 1992. The natural history of community-acquired hepatitis C in the United States. New Engl J Med 327:1899-1905.

American Conference of Governmental Industrial Hygienists (ACGIH). 1991. Documentation of the Threshold Limit Values and Biological Exposure Indices, 6th edition. Cincinnati, OH: ACGIH.

—. 1994. TLVs: Threshold Limit Values and Biological Exposure Indices for 1994-1995. Cincinnati, OH: ACGIH.

American Hospital Association (AHA). 1992. Implementing Safer Needle Practice. Chicago, IL: AHA.

American Institute of Architects. 1984. Determining Hospital Space Requirements. Washington, DC: American Institute of Architects Press.

American Institute of Architects Committee on Architecture for Health. 1987. Guidelines for Construction and Equipment of Hospital and Medical Facilities. Washington, DC: American Institute of Acrchitects Press.

American Society of Heating, Refrigerating and Air-conditioning Engineers (ASHRAE). 1987. Health facilities. In ASHRAE Handbook: Heating, Ventilating and Air-conditioning Systems and Applications. Atlanta, GA: ASHRAE.

Anon. 1996. New drugs for HIV infection. Medical Letter of Drugs and Therapeutics 38:37.

Axelsson, G, R Rylander, and I Molin. 1989. Outcome of pregnancy in relation to irregular and inconvenient work schedules. Brit J Ind Med 46:393-398.

Beatty, J SK Ahern, and R Katz. 1977. Sleep deprivation and the vigilance of anesthesiologists during simulated surgery. In Vigilance, edited by RR Mackie. New York: Plenum Press.

Beck-Friis, B, P Strang, and PO Sjöden. 1991. Work stress and job satisfaction in hospital-based home care. Journal of Palliative Care 7(3):15-21.

Benenson, AS (ed.). 1990. Control of Communicable Disease in Man, 15th edition. Washington, DC: American Public Health Association.

Bertold, H, F Hofmann, M Michaelis, D Neumann-Haefelin, G Steinert, and J Wölfle. 1994. Hepatitis C—Risiko für Beschäftigte im Gesundheitsdienst? In Arbeitsmedizin im Gesundheitsdienst, Band 7, edited by F Hofmann, G Reschauer, and U Stössel. Stuttgart: Gentner Verlag.

Bertram, DA. 1988. Characteristics of shifts and second-year resident performance in an emergency department. NY State J Med 88:10-14.

Berufsgenossenschaft für Gesundheitsdienst und Wohlfahrtspflege (BGW). 1994. Geschäftsbericht.

Bissel, L and R Jones. 1975. Disabled doctors ignored by peers. Presented at the American Medical Association Conference on the Imparied Physician, 11 April, San Francisco, CA.

Bitker, TE. 1976. Reaching out to the depressed physician. JAMA 236(15):1713-1716.

Blanchard, M, MM Cantel, M Faivre, J Girot, JP Ramette, D Thely, and M Estryn-Béhar. 1992. Incidence des rythmes biologiques sur le travail de nuit. In Ergonomie à l’hôpital, edited by M Estryn-Béhar, C Gadbois, and M Pottier. Toulouse: Edition Octares.

Blanpain, C and M Estryn-Béhar. 1990. Measures d’ambiance physique dans dix services hospitaliers. Performances 45:18-33.

Blaycock, B. 1995. Latex allergies: Overview, prevention and implications for nursing care. Ostomy Wound Manage 41(5):10-12,14-15.

Blazer, MJ, FJ Hickman, JJ Farmer, and DJ Brenner. 1980. Salmonella typhi: The laboratory as a reservoir of infection. Journal of Infectious Diseases 142:934-938.

Blow, RJ and MIV Jayson. 1988. Back pain. In Fitness for Work: The Medical Approach, edited by FC Edwards, RL McCallum, and PJ Taylor. Oxford: Oxford University Press.

Boehm, G and E Bollinger. 1990. Significance of environmental factors on the tolerated enteral feeding volumes for patients in neonatal intensive care units. Kinderarzliche Praxis 58(6):275-279.

Bongers, P, RD Winter, MAJ Kompier, and VV Hildebrandt. 1992. Psychosocial Factors at Work and Musculoskeletal Diseases. Review of the literature. Leiden, Netherlands: TNO.

Bouhnik, C, M Estryn-Béhar, B Kapitaniak, M Rocher, and P Pereau. 1989. Le roulage dans les établissements de soins. Document pour le médecin du travail. INRS 39:243-252.

Boulard, R. 1993. Les indices de santé mentale du personnel infirmier: l’impact de la charge de travail, de l’autonomie et du soutien social. In La psychologie du travail à l’aube du XXI° siècle. Actes du 7° Congrès de psychologie du travail de langue française. Issy-les-Moulineaux: Editions EAP.

Breakwell, GM. 1989. Facing Physical Violence. London: British Psychological Society.

Bruce, DL and MJ Bach. 1976. Effects of Trace Concentrations of Anesthetic Gases on Behavioral Performance of Operating Room Personnel. DHEW (NIOSH) Publication No. 76-169. Cincinnati, OH: NIOSH.

Bruce, DL, KA Eide, HW Linde, and JE Eckenhoff. 1968. Causes of death among anesthesiologists: A 20 years survey. Anesthesiology 29:565-569.

Bruce, DL, KA Eide, NJ Smith, F Seltzer, and MH Dykes. 1974. A prospective survey of anesthesiologists’ mortality, 1967-1974. Anesthesiology 41:71-74.

Burhill, D, DA Enarson, EA Allen, and S Grzybowski. 1985. Tuberculosis in female nurses in British Columbia. Can Med Assoc J 132:137.

Burke, FJ, MA Wilson, and JF McCord. 1995. Allergy to latex gloves in clinical practice: Case reports. Quintessence Int 26(12):859-863.

Buring, JE, CH Hennekens, SL Mayrent, B Rosner, ER Greenberg, and T Colton. 1985. Health experiences of operating room personnel. Anesthesiology 62: 325-330.

Burton, R. 1990. St. Mary’s Hospital, Isle of Wight: A suitable background for caring. Brit Med J 301:1423-1425.

Büssing, A. 1993. Stress and burnout in nursing: Studies in different work structures and work schedules. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech: Ecomed Verlag.

Cabal, C, D Faucon, H Delbart, F Cabal, and G Malot. 1986. Construction d’une blanchisserie industrielle aux CHU de Saint-Etienne. Arch Mal Prof 48(5):393-394.

Callan, JR, RT Kelly, ML Quinn, JW Gwynne, RA Moore, FA Muckler, J Kasumovic, WM Saunders, RP Lepage, E Chin, I Schoenfeld, and DI Serig. 1995. Human Factors Evaluation of Remote Afterloading Brachytherapy. NUREG/CR-6125. Vol. 1. Washington, DC: Nuclear Regulatory Commission

Cammock, R. 1981. Primary Health Care Buildings: Briefing and Design Guide for Architects and Their Clients. London: Architectural Press.

Cardo, D, P Srivastava, C Ciesielski, R Marcus, P McKibben, D Culver, and D Bell. 1995. Case-control study of HIV seroconversion in health care workers after percutaneous exposure to HIV-infected blood (abstract). Infect Control Hosp Epidemiol 16 suppl:20.

Carillo, T, C Blanco, J Quiralte, R Castillo, M Cuevas, and F Rodriguez de Castro. 1995. Prevalence of latex allergy among greenhouse workers. J Allergy Clin Immunol 96(5/1):699-701.

Catananti, C and A Cambieri. 1990. Igiene e Tecnica Ospedaliera (Hospital Hygiene and Organization). Roma: II Pensiero Scientifico Editore.

Catananti, C, G Damiani, G Capelli, and G Manara. 1993. Building design and selection of materials and furnishings in the hospital: A review of international guidelines. In Indoor Air ’93, Proceedings of the 6th International Conference on Indoor Air Quality and Climate 2:641-646.

Catananti, C, G Capelli, G Damiani, M Volpe, and GC Vanini. 1994. Multiple criteria evaluation in planning selection of materials for health care facilities. Preliminary identification of criteria and variables. In Healthy Buildings ’94, Proceedings of the 3rd International Conference 1:103-108.

Cats-Baril, WL and JW Frymoyer. 1991. The economics of spinal disorders. In The Adult Spine, edited by JW Frymoyer. New York: Raven Press.

Centers for Disease Control (CDC). 1982. Acquired immunodeficiency syndrome (AIDS): Precautions for clinical laboratory staffs. Morb Mortal Weekly Rep 31:577-580.

—. 1983. Acquired immunodeficiency syndrome (AIDS): Precautions for health-care workers and allied professionals. Morb Mortal Weekly Rep 32:450-451.

—. 1987a. Human immunodeficiency virus infection in health-care workers exposed to blood of infected patients. Morb Mortal Weekly Rep 36:285-289.

—. 1987b. Recommendations for prevention of HIV transmission in health-care settings. Morb Mortal Weekly Rep 36 suppl 2:3S-18S.

—. 1988a. Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. Morb Mortal Weekly Rep 37:377-382,387-388.

—. 1988b. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. Morb Mortal Weekly Rep 37 suppl 6:1-37.

—. 1989. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. Morb Mortal Weekly Rep 38 suppl 6.

—. 1990. Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding post-exposure use. Morb Mortal Weekly Rep 39 (No. RR-1).

—. 1991a. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP). Morb Mortal Weekly Rep 40 (No. RR-13).

—. 1991b. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. Morb Mortal Weekly Rep 40 (No. RR-8).

—. 1993a. Recommended infection-control practices in dentistry. Morb Mortal Weekly Rep 42 (No. RR-8):1-12.

—. 1993b. Biosafety in Microbial and Biomedical Laboratories, 3rd edition. DHHS (CDC) Publication No. 93-8395. Atlanta, GA: CDC.

—. 1994a. HIV/AIDS Surveillance Report. Vol. 5(4). Atlanta, GA: CDC.

—. 1994b. HIV/AIDS Prevention Newsletter. Vol. 5(4). Atlanta, GA: CDC.

—. 1994c. Human immunodeficiency virus in household settings—United States. Morb Mortal Weekly Rep 43:347-356.

—. 1994d. HIV/AIDS Surveillance Report. Vol. 6(1). Atlanta, GA: CDC.

—. 1994e. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities. Morb Mortal Weekly Rep 43 (No. RR-13):5-50.

—. 1995. Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood—France, United Kingdom, and United States. Morb Mortal Weekly Rep 44:929-933.

—. 1996a. HIV/AIDS Surveillance Report. Vol 8(2). Atlanta, GA: CDC.

—. 1996b. Update: Provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV. Morb Mortal Weekly Rep 45:468-472.

Charney, W (ed.). 1994. Essentials of Modern Hospital Safety. Boca Raton, FL: Lewis Publishers.

Chou, T, D Weil, and P Arnmow. 1986. Prevalence of measles antibodies in hospital personnel. Infec Contr Hosp Epid 7:309-311.

Chriske, H and A Rossa. 1991. Hepatitis-C-Infektionsgefährdung des medizinischen Personals. In Arbeitsmedizin im Gesundheitsdienst, Band 5, edited by F Hofmann and U Stössel. Stuttgart: Gentner Verlag.

Clark, DC, E Salazar-Gruesco, P Grabler, J Fawcett. 1984. Predictors of depression during the first 6 months of internship. Am J Psychiatry 141:1095-1098.

Clemens, R, F Hofmann, H Berthold, and G Steinert. 1992. Prävalenz von Hepatitis, A, B und C bei Bewohern einer Einrichtung für geistig Behinderte. Sozialpädiatrie 14:357-364.

Cohen, EN. 1980. Anasthetic Exposure in the Workplace. Littleton, MA: PSG Publishing Co.

Cohen, EN, JW Bellville, and BW Brown, Jr. 1971. Anesthesia, pregnancy and miscarriage: A study of operating room nurses and anesthetists. Anesthesiology 35:343-347.

—. 1974. Occupational disease among operating room personnel: A national study. Anesthesiology 41:321-340.

—. 1975. A survey of anethestic health hazards among dentists. J Am Dent Assoc 90:1291-1296.

Commission of the European Communities. 1990. Recommendation of the Commission February 21, 1990, about Protection of People against Exposure to Radon in Indoor Environments. 90/143/Euratom (Italian Translation).

Cooper, JB. 1984. Toward prevention of anesthesic mishaps. International Anesthesiology Clinics 22:167-183.

Cooper, JB, RS Newbower, and RJ Kitz. 1984. An analysis of major errors and equipment failures in anesthesia management: Considerations for prevention and detection. Anesthesiology 60(1):34-42.

Costa, G, R Trinco, and G Schallenberg. 1992. Problems of thermal comfort in an operating room equipped with laminar air flow system In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar M, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Cristofari, M-F, M Estryn-Béhar, M Kaminski, and E Peigné. 1989. Le travail des femmes à l’hôpital. Informations Hospitalières 22/23:48-62.

Council of the European Communities. 1988. Directive December 21, 1988, to Draw Near the Laws of Member Countries about Building Products. 89/106/EEC (Italian translation).

de Chambost, M. 1994. Alarmes sonnantes, soignantes trébuchantes. Objectif soins 26:63-68.

de Keyser, V and AS Nyssen. 1993. Les erreurs humaines en anesthésies. Le Travail humain 56(2/3):243-266.

Decree of the President of Ministers Council. 1986. Directive to the Regions about Private Health Care Facilities Requirements. 27 June.

Dehlin, O, S Berg, GBS Andersson, and G Grimby. 1981. Effect of physical training and ergonomic counselling on the psychosocial perception of work and on the subjective assesment of low-back insuffuciency. Scand J Rehab 13:1-9.

Delaporte, MF, M Estryn-Béhar, G Brucker, E Peigne, and A Pelletier. 1990. Pathologie dermatologique et exercice professionnel en milieu hospitalier. Arch Mal Prof 51(2):83-88.

Denisco, RA, JN Drummond, and JS Gravenstein. 1987. The effect of fatigue on the performance of a simulated anesthetic monitoring task. J Clin Monit 3:22-24.

Devienne, A, D Léger, M Paillard, A Dômont. 1995. Troubles du sommeil et de la vigilance chez des généralistes de garde en région parisienne. Arch Mal Prof 56(5):407-409.

Donovan, R, PA Kurzman, and C Rotman. 1993. Improving the lives of home care workers: A partnership of social work and labor. Soc Work 38(5):579-585..

Edling, C. 1980. Anesthetic gases as an occupational hazard. A review. Scand J Work Environ Health 6:85-93.

Ehrengut, W and T Klett. 1981. Rötelnimmunstatus von Schwesternschülerinnen in Hamberger Krankenhäusern im Jahre 1979. Monatsschrift Kinderheilkdunde 129:464-466.

Elias, J, D Wylie, A Yassi, and N Tran. 1993. Eliminating worker exposure to ethylene oxide from hospital sterilizers: An evaluation of cost and effectiveness of an isolation system. Appl Occup Environ Hyg 8(8):687-692.

Engels, J, TH Senden, and K Hertog. 1993. Working postures of nurses in nursing homes. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech: Ecomed Verlag.

Englade J, E Badet and G Becque. 1994. Vigilance et qualité de sommeil des soignants de nuit. Revue de l’infirmière 17:37-48.

Ernst, E and V Fialka. 1994. Idiopathic low back pain: Present impact, future directions. European Journal of Physical Medicine and Rehabilitation 4:69-72.

Escribà Agüir, V. 1992. Nurses’ attitudes towards shiftwork and quality of life, Scand J Soc Med 20(2):115-118.

Escribà Agüir V, S Pérez, F Bolumar, and F Lert. 1992. Retentissement des horaires de travail sur le sommeil des infirmiers. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Estryn-Béhar, M. 1990. Les groupes de parole: Une stratégie d’amélioration des relations avec les malades. Le concours médical 112(8):713-717.

—. 1991. Guide des risques professionnels du personnel des services de soins. Paris: Editions Lamarre.

Estryn-Béhar, M and N Bonnet. 1992. Le travail de nuit à l’hôpital. Quelques constats à mieux prendre en compte. Arch Mal Prof 54(8):709-719.

Estryn-Béhar, M and F Fonchain. 1986. Les troubles du sommeil du personnel hospitalier effectuant un travail de nuit en continu. Arch Mal Prof 47(3):167-172;47(4):241.

Estryn-Béhar, M and JP Fouillot. 1990a. Etude de la charge physique du personnel soignant, Documents pour le médecin du travail. INRS: 27-33.

—. 1990b. Etude de la charge mentale et approche de la charge psychique du personnel soignant. Analyse du travail des infirmières et aides-soignantes dans 10 services de soins. Documents pour le médecin du travail INRS 42:131-144.

Estryn-Béhar, M and C Hakim-Serfaty. 1990. Organisation de l’espace hospitalier. Techn hosp 542:55-63.

Estryn-Béhar, M and G Milanini. 1992. Concevoir les espaces de travail en services de soins. Technique Hospitalière 557:23-27.

Estryn-Béhar, M and H Poinsignon. 1989. Travailler à l’hopital. Paris: Berger Levrault.

Estryn-Béhar, M, C Gadbois, and E Vaichere. 1978. Effets du travail de nuit en équipes fixes sur une population féminine. Résultats d’une enquête dans le secteur hospitalier. Arch Mal Prof 39(9):531-535.

Estryn-Béhar, M, C Gadbois, E Peigné, A Masson, and V Le Gall. 1989b. Impact of nightshifts on male and female hospital staff, in Shiftwork: Health and Performance, edited by G Costa, G Cesana, K Kogi, and A Wedderburn. Proceedings of the International Symposium on Night and Shift Work. Frankfurt: Peter Lang.

Estryn-Béhar, M, M Kaminski, and E Peigné. 1990. Strenuous working conditions and musculoskeletal disorders among female hospital workers. Int Arch Occup Environ Health 62:47-57.

Estryn-Béhar, M, M Kaminski, M Franc, S Fermand, and F Gerstle F. 1978. Grossesse er conditions de travail en milieu hospitalier. Revue franç gynec 73(10) 625-631.

Estryn-Béhar, M, M Kaminski, E Peigné, N Bonnet, E Vaichère, C Gozlan, S Azoulay, and M Giorgi. 1990. Stress at work and mental health status. Br J Ind Med 47:20-28.

Estryn-Béhar, M, B Kapitaniak, MC Paoli, E Peigné, and A Masson. 1992. Aptitude for physical exercise in a population of female hospital workers. Int Arch Occup Environ Health 64:131-139.

Estryn Béhar, M, G Milanini, T Bitot, M Baudet, and MC Rostaing. 1994. La sectorisation des soins: Une organisation, un espace. Gestion hospitalière 338:552-569.

Estryn-Béhar, M, G Milanini, MM Cantel, P Poirier, P Abriou, and the ICU’s study group. 1995a. Interest of participative ergonomic methodology to improve an intensive care unit. In Occupational Health for Health Care Workers, 2nd edition, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech: Ecomed Verlag.

—. 1995b. Participative ergonomic methodology for the new fitting out of a cardiologic intensive care unit. In Occupational Health for Health Care Workers, 2nd edition, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech: Ecomed Verlag.

Estryn-Béhar, M, E Peigné, A Masson, C Girier-Desportes, JJ Guay, D Saurel, JC Pichenot, and J Cavaré. 1989a. Les femmes travaillant à l’hôpital aux différents horaires, qui sont-elles? Que décrivent-elles comme conditions de travail? Que souhaitent-elles? Arch Mal Prof 50(6):622-628.

Falk, SA and NF Woods. 1973. Hospital noise-levels and potential health hazards, New England J Med 289:774-781.

Fanger, PO. 1973. Assessment of man’s thermal comfort in practice. Br J Ind Med 30:313-324.

—. 1992. Sensory characterization of air quality and pollution sources. In Chemical, Microbiological, Health and Comfort Aspects of Indoor Air Quality—State of the Art in SBS, edited by H Knoppel and P Wolkoff. Dordrecht, NL: Kluwer Academic Publishers.

Favrot-Laurens. 1992. Advanced technologies and work organization of hospital teams. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

—. 1992. Sensory characterization of air quality and pollution sources. In Chemical, Microbiological, Health and Comfort Aspects of Indoor Air Quality—State of the Art in Sick Building Syndrome, edited by H Koppel and P Wolkoff. Brussels and Luxembourg: EEC.

Ferstandig, LL. 1978. Trace concentrations of anesthetic gases: A critical review of their disease potential. Anesth Analg 57:328-345.

Finley, GA and AJ Cohen. 1991. Percieved urgency and the anaesthetist: Responses to common operating room monitor alarms. Can J Anaesth 38(8):958-964

Ford, CV and DK Wentz. 1984. The internship year: A study of sleep, mood states, and psychophysiologic parameters. South Med J 77:1435-1442.

Friedman, RC, DS Kornfeld, and TJ Bigger. 1971. Psychological problems associated with sleep deprivation in interns. Journal of Medical Education 48:436-441.

Friele, RD and JJ Knibbe. 1993. Monitoring the barriers with the use of patient lifts in home care as perceived by nursing personnel. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. LandsbergLech: Ecomed Verlag.

Gadbois, CH. 1981. Aides-soignantes et infirmières de nuit. In Conditions de travail et vie quotidienne. Montrougs: Agence Nationale pour l’Amélioration des Conditions de Travail.

Gadbois, C, P Bourgeois, MM Goeh-Akue-Gad, J Guillaume, and MA Urbain. 1992. Contraintes temporelles et structure de l’espace dans le processus de travail des équipes de soins. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Games, WP, and W Tatton-Braen. 1987. Hospitals Design and Development. London: Architectural Press.

Gardner, ER and RC Hall. 1981. The professional stress syndrome. Psychosomatics 22:672-680.

Gaube, J, H Feucht, R Laufs, D Polywka, E Fingscheidt, and HE Müller. 1993. Hepatitis A, B und C als desmoterische Infecktionen. Gessundheitwesen und Desinfextion 55:246-249.

Gerberding, JL. N.d. Open trial of Zidovudine Postexposure-chemoprophylaxis in Health Care Workers with Occupational Exposures to Human Immunodeficiency Virus. Skript SFGH.

—. 1995. Management of occupational exposures to blood-borne viruses. New Engl J Med 332:444-451.

Ginesta, J. 1989. Gases anestésicos. In Riesgos del Trabajo del Personal Sanitario, edited by JJ Gestal. Madrid: Editorial Interamericana McGraw-Hill.

Gold, DR, S Rogacz, N Bock, TD Tosteson, TM Baum, FE Speizer, and CA Czeiler. 1992. Rotating shift work, sleep and accidents related to sleepiness in hospital nurses. Am J Public Health 82(7):1011-1014.

Goldman, LI, MT McDonough, and GP Rosemond. 1972. Stresses affecting surgical performance and learning: Correlation of heart rate, electrocardiogram, and operation simultaneously recorded on videotapes. J Surg Res 12:83-86.

Graham, C, C Hawkins, and W Blau. 1983. Innovative social work practice in health care: Stress management. In Social Work in a Turbulent World, edited by M Dinerman. Washington, DC: National Association of Social Workers.

Green, A. 1992. How nurses can ensure the sounds patients hear have a positive rather than negative effect upon recovery and quality of life. Intensive & Critical Care Nursing Journal 8(4):245-248.

Griffin, WV. 1995. Social worker and agency safety. In Encyclopaedia of Social Work, 19th edition. Washington, DC: National Association of Social Workers.

Grob, PJ. 1987. Cluster of hepatitis B transmission by a physician. Lancet 339:1218-1220.

Guardino, X and MG Rosell. 1985. Exposicion laboral a gases anestésicos. In Notas Técnicas de Prevención. No. 141. Barcelona: INSHT.

—. 1992. Exposure at work to anesthetic gases. A controlled risk? Janus 12:8-10.

—. 1995. Exposure monitoring to anesthetic gases. In Occupational Health for Health Care Workers, edited by M Hagburg, F Hoffmann, U Stössel, and G Westlander. Solna: National Institute of Occupational Health.

Hagberg, M, F Hofmann, U Stössel, and G Westlander (eds.). 1993. Occupational Health for Health Care Workers. Landsberg/Lech: Ecomed Verlag.

Hagberg, M, F Hofmann, U Stössel, and G Westlander (eds.). 1995. Occupational Health for Health Care Workers. Singapore: International Commission on Occupational Health.

Haigh, R. 1992. The application of ergonomics to the design of workplace in health care buildings in the U.K. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Halm, MA and MA Alpen, 1993. The impact of technology on patient and families. Nursing Clinics of North America 28(2):443-457.

Harber, P, L Pena, and P Hsu. 1994. Personal history, training, and worksite as predictors of back pain of nurses. Am J Ind Med 25:519-526.

Hasselhorn, HM. 1994. Antiretrovirale prophylaxe nach kontakt mit HIV-jontaminierten. In Flüssigkeiten in Infektiologie, edited by F Hofmann. Landsberg/Lech: Ecomed Verlag.

Hasselhorn, HM and E Seidler.1993. Terminal care in Sweden—New aspects of the professional care of dying. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel U, and G Westlander. Landsberg/Lech: Ecomed Verlag.

Heptonstall, J, K Porter, and N Gill. 1993. Occupational Transmission of HIV: Summary of Published Reports. London: Communicable Disease Surveillance Centre AIDS Centre.

Hesse, A, Lacher A, HU Koch, J Kublosch, V Ghane, and KF Peters. 1996. Update on the latex allergy topic. Hauzarzt 47(11):817-824.

Ho, DD, T Moudgil, and M Alam. 1989. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. New Engl J Med 321:1621-1625.

Hodge, B and JF Thompson. 1990. Noise pollution in the operating theatre. Lancet 335:891-894.

Hofmann, F and H Berthold. 1989. Zur Hepatitis-B-Gefährdung des Krankenhauspersonals-Möglichkeiten der prae-und postexpositionellen Prophylaxe. Medizinische Welt 40:1294-1301.

Hofmann, F and U Stössel. 1995. Environmental health in the health care professions: Biological, physical, psychic, and social health hazards. Reviews on Environmental Health 11:41-55.

Hofmann, F, H Berthold, and G Wehrle. 1992. Immunity to hepatitis A in hospital personnel. Eur J Clin Microbiol Infect Dis 11(12):1195.

Hofmann, F, U Stössel, and J Klima. 1994. Low back pain in nurses (I). European Journal of Physical and Medical Rehabilitation 4:94-99.

Hofmann, F, B Sydow, and M Michaelis. 1994a. Mumps—berufliche Gefährdung und Aspekte der epidemiologischen Entwicklung. Gessundheitwesen und Desinfextion 56:453-455.

—. 1994b. Zur epidemiologischen Bedeutung der Varizellen. Gessundheitwesen und Desinfextion 56:599-601.

Hofmann, F, G Wehrle, K Berthold, and D Köster. 1992. Hepatitis A as an occupational hazard. Vaccine 10 suppl 1:82-84.

Hofmann, F, U Stössel, M Michaelis, and A Siegel. 1993. Tuberculosis—Occupational risk for health care workers? In Occupational Health for Health Care Workers, edited by M Hagberg. Landsberg/Lech: Ecomed Verlag.

Hofmann, F, M Michaelis, A Siegel, and U Stössel. 1994. Wirbelsäulenerkrankungen im Pflegeberuf. Medizinische Grundlagen und Prävention. Landsberg/Lech: Ecomed Verlag.

Hofmann, F, M Michaelis, M Nübling, and FW Tiller. 1995. European Hepatitis—A Study. Publikation in Vorereitung.

Hofmann, H and C Kunz. 1990. Low risk of health care workers for infection with hepatitis-C virus. Infection 18:286-288.

Holbrook, TL, K Grazier, JL Kelsey, and RN Stauffer. 1984. The Frequency of Occurrence, Impact, and Cost of Selected Musculoskeletal Conditions in the United States. Park Ridge, Il: American Academy of Orthopedic Surgeons.

Hollinger, FB. 1990. Hepatitis B virus. In Virology, edited by BN Fiedles and DM Knipe. New York: Raven Press.

Hopps, J and P Collins. 1995. Social work profession overview. In Encyclopedia of Social Work, 19th edition. Washington, DC: National Association of Social Workers.

Hubacova, L, I Borsky, and F Strelka. 1992. Work physiology problems of nurses working in inpatients departments. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Hunt, LW, AF Fransway, CE Reed, LK Miller, RT Jones, MC Swanson, and JW Yunginger. 1995. An epidemic of occupational allergy to latex involving health care workers. J Occup Environ Med 37(10):1204-1209.

Jacobson, SF and HK MacGrath. 1983. Nurses under Stress. New York: John Wiley & Sons.

Jacques, CHM, MS Lynch and JS Samkoff. 1990. The effects of sleep loss on cognitive performance of resident physicians. J Fam Pract 30:223-229.

Jagger, J, EH Hunt, J Brand-Elnagger, and RD Pearson. 1988. Rates of needle-stick injury caused by various devices in a university hospital. New Engl J Med 319:284-288.

Johnson, JA, RM Buchan, and J S Reif. 1987. Effect of waste anesthetic gas and vapor exposure on reproductive outcome in veterinary personnel. Am Ind Hyg Assoc J 48(1):62-66.

Jonasson, G, JO Holm, and J Leegard. Rubber allergy: An increasing health problem? Tuidsskr Nor Laegeforen 113(11):1366-1367.

Kandolin, I. 1993. Burnout of female and male nurses in shiftwork. Ergonomics 36(1/3):141-147.

Kaplan, RM and RA Deyo. 1988. Back pain in health care workers. In Back Pain in Workers, edited by RA Deyo. Philadelphia, PA: Hanley & Belfus.

Katz, R. 1983. Causes of death among nurses. Occup Med 45:760-762.

Kempe, P, M Sauter and I Lindner. 1992. Special characteristics of nurses for the aged who made use of a training program aimed to reduce burn-out symptoms and first results on treatment outcome. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Kerr, JH. 1985. Warning devices. Br J Anaesth 57:696-708.

Kestin, IG, RB Miller, and CJ Lockhart. 1988. Auditory alarms during anesthesia monitoring. Anesthesiology 69(1):106-109.

Kinloch-de-los, S, BJ Hirschel, B Hoen, DA Cooper, B Tindall, A Carr, H Sauret, N Clumeck, A Lazzarin, and E Mathiesen. 1995. A controlled trial of Zidovudine in primary human immunodeficiency virus infection. New Engl J Med 333:408-413.

Kivimäki, M and K Lindström. 1995. The crucial role of the head nurse in a hospital ward. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech: Ecomed Verlag.

Klaber Moffet, JA, SM Chase, I Portek, and JR Ennis. 1986. A controlled study to evaluate the efectiveness of the back pain school in the relief of chronic low back pain. Spine 11:120-122.

Kleczkowski, BM, C Montoya-Aguilar, and NO Nilsson. 1985. Approaches to Planning and Design of Health Care Facilities in Developing Areas. Vol. 5. Geneva: WHO.

Klein, BR and AJ Platt. 1989. Health Care Facility Planning and Construction. New York: Van Nostrand Reinhold.

Kelin, R, K Freemann, P Taylor, C Stevens. 1991. Occupational risk for hepatits C virus infection among New York City dentists. Lancet 338:1539-1542.

Kraus, H. 1970. Clinical Treatment of Back and Neck Pain. New York: McGraw-Hill.

Kujala, VM and KE Reilula. 1995. Glove-induced dermal and respiratory symptoms among health care workers in one Finnish hospital. Am J Ind Med 28(1):89-98.

Kurumatani, N, S Koda, S Nakagiri, K Sakai, Y Saito, H Aoyama, M Dejima, and T Moriyama. 1994. The effects of frequently rotating shiftwork on sleep and the family life of hospital nurses. Ergonomics 37:995-1007.

Lagerlöf, E and E Broberg. 1989. Occupational injuries and diseases. In Occupational Hazards in the Health Professions, edited by DK Brune and C Edling. Boca Raton, FL: CRC Press.

Lahaye, D, P Jacques, G Moens, and B Viaene. 1993. The registration of medical data obtained by preventive medical examinations on health care workers. In Occupational Health for Health Care Workers, edited by M Hagberg, F Hofmann, F, U Stössel and G Westlander. Landsberg/Lech: Ecomed Verlag.

Lampher, BP, CC Linneman, CG Cannon, MM DeRonde, L Pendy, and LM Kerley. 1994. Hepatitis C virus infection in health care workers: Risk of exposure and infection. Infect Control Hosp Epidemiol 15:745-750.

Landau, C, S Hall, SA Wartman, and MB Macko. 1986. Stress in social and family relationships during medical residency. Journal of Medical Education 61:654-660.

Landau, K. 1992. Psycho-physical strain and the burn-out phenomen amongst health care professionals. In Ergonomie à l’hôpital (Hospital Ergonomics), edited by M Estryn-Béhar, C Gadbois, and M Pottier. International Symposium Paris 1991. Toulouse: Editions Octares.

Landewe, MBM and HT Schröer. 1993. Development of a new, integrated patient transfer training program—Primary prevention of low back pain. In Occupational Health for Health Care Workers, editeb by M Hagberg, F Hofmann, U Stössel, and G Westlander. Landsberg/Lech: Ecomed Verlag.

Lange, M. 1931. Die Muskelhärten (Myogelosen). Munich: JF Lehman Verlag.

Lange, W and KN Masihi. 1986. Durchseuchung mit Hepatitis-A- und B-Virus bei medizinischem Personal. Bundesgesundheitsol 29;183-87.

Lee, KA. 1992. Self-reported sleep disturbances in employed women. Sleep15(6):493-498.

Lempereur, JJ. 1992. Prévention des dorso-lombalgies. Influence du vêtement de travail sur le comportement gestuel. Spécifications ergonomiques. Cah Kinésither 156,:4.

Leppanen, RA and MA Olkinuora. 1987. Psychological stress experienced by health care personnel. Scand J Work Environ Health 13:1-8.

Lert, F, MJ Marne, and A Gueguen. 1993. Evolution des conditions de travail des infirmières des hôpitaux publics de 1980 à 1990. Revue de l’Epidémiologie et de santé publique 41:16-29.

Leslie, PJ, JA Williams, C McKenna, G Smith and RC Heading. 1990. Hours, volume, and type of work of preregistration house officers. Brit Med J 300:1038-1041.

Lettau, LA, HJ Alfred, RH Glew, HA Fields, MJ Alter, R Meyer, SC Hadler, and JE Maynard. 1986. Nosocomial transmission of delta hepatitis. Ann Intern Med 104:631-635.

Levin, H. 1992. Healthy buildings—Where do we stand, where do we go? In Chemical, Microbiological, Health and Comfort Aspects of Indoor Air Quality: State of the Art in Sick Building Syndrome, edited by H Knoppel and P Wolkoff. Brussels and Luxembourg: EEC.

Lewittes, LR and VW Marshall. 1989. Fatigue and concerns about quality of care among Ontario interns and residents. Can Med Assoc J 140:21-24.

Lewy, R. 1990. Employees at Risk: Protection and Health of Health Care Workers. New York: Van Nostrand Reinhold.

Lindström, A and M Zachrisson. 1973. Ryggbesvär och arbetssoförmaga Ryyggskolan. Ett Försok till mer rationeli fysikalist terapi. Socialmet T 7:419-422.

Lippert. 1971. Travel in nursing units. Human Factors 13(3):269-282.

Ljungberg, AS, A Kilbom, and MH Goran. 1989. Occupational lifting by nursing aides and warehouse workers. Ergonomics 32:59-78.

Llewelyn-Davies, R and J Wecks. 1979. In-patient areas. In Approaches to Planning and Design of Health Care Facilities in Developing Areas, edited by BM Kleczkowski and R Piboleau. Geneva: WHO.

Loeb, RG, BR Jones, KH Behrman, and RJ Leonard. 1990. Anesthetists cannot identify audible alarms. Anesthesiology 73(3A):538.

Lotas, MJ. 1992. Effects of light and sound in the neonatal intensive care unit environment on the low-birth-weight infant. NAACOGS Clinical Issues in Perinatal & Womens Health Nursing 3(1):34-44.

Lurie, HE, B Rank, C Parenti, T Wooley, and W Snoke. 1989. How do house officers spend their nights? A time study of internal medicine house staff on call. New Engl J Med 320:1673-1677.

Luttman, A, M Jäger, J Sökeland, and W Laurig. 1996. Electromyographical study on surgeons in urology II. Determination of muscular fatigue. Ergonomics 39(2):298-313.

Makino, S. 1995. Health problems in health care workers in Japan. In Occupational He